NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

InspireMD logo
$0.65 +0.05 (+8.33%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$0.62 -0.03 (-4.31%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About InspireMD Stock (NYSE:NSPR)

Advanced

Key Stats

Today's Range
$0.57
▼
$0.68
50-Day Range
$0.44
▼
$0.81
52-Week Range
$0.43
▼
$2.17
Volume
495,653 shs
Average Volume
173,700 shs
Market Capitalization
$30.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50
Consensus Rating
Buy

Company Overview

InspireMD is a medical technology company focused on developing devices for the treatment of carotid artery disease, a condition that can increase the risk of stroke. The company’s technology is designed to help protect against debris traveling to the brain during procedures to open narrowed arteries.

Its lead product is the CGuard carotid stent system, which combines a metal stent with a fine mesh covering called MicroNet. The mesh is designed to help trap plaque and other material while allowing blood to flow through the artery. InspireMD has also developed stent technology for other vascular applications.

Headquartered in Israel, InspireMD serves markets internationally and has pursued regulatory approvals to expand the availability of its products. The company’s work centers on advancing embolic-protection technology for vascular procedures.

AI Generated. May Contain Errors.

InspireMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

NSPR MarketRank™: 
2.7510655301 of 5 stars

InspireMD scored higher than 55% of companies evaluated by MarketBeat, and ranked 448th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    InspireMD has a consensus price target of $4.50, representing about 592.3% upside from its current price of $0.65.

  • Amount of Analyst Coverage

    InspireMD has received no research coverage in the past 90 days.

  • Read more about InspireMD's stock forecast and price target.
  • Earnings Growth

    Earnings for InspireMD are expected to grow in the coming year, from ($0.79) to ($0.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InspireMD is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InspireMD is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InspireMD has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NSPR.
  • Dividend Yield

    InspireMD does not currently pay a dividend.

  • Dividend Growth

    InspireMD does not have a long track record of dividend growth.

  • News Sentiment

    InspireMD has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for InspireMD this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for NSPR on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InspireMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    24.98% of the stock of InspireMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.78% of the stock of InspireMD is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InspireMD's insider trading history.
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NSPR Stock News Headlines

Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this fall.tc pixel
InspireMD (NSPR) Q3 2026 Earnings Call Transcript
InspireMD Announces Pricing of $37.5 Million Public Offering
See More Headlines

NSPR Stock Analysis - Frequently Asked Questions

InspireMD's stock was trading at $1.78 at the beginning of 2026. Since then, NSPR shares have decreased by 63.5% and is now trading at $0.65.

InspireMD, Inc. (NYSE:NSPR) posted its earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.04. The firm had revenue of $1.81 million for the quarter, compared to analyst estimates of $1.74 million. InspireMD had a negative net margin of 413.96% and a negative trailing twelve-month return on equity of 69.42%.

InspireMD (NSPR) raised $10,000 in an initial public offering (IPO) on Friday, May 21st 2021. The company issued 2,000,000 shares at a price of $0.00-$0.01 per share.

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:NSPR
CIK
1433607
Fax
N/A
Employees
127
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$3.00
Potential Upside/Downside
+592.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.92 million
Net Margins
-413.96%
Pretax Margin
-413.00%
Return on Equity
-69.42%
Return on Assets
-57.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.39
Quick Ratio
6.05

Sales & Book Value

Annual Sales
$10.84 million
Price / Sales
2.79
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.83 per share
Price / Book
0.36

Miscellaneous

Outstanding Shares
46,489,000
Free Float
18,332,000
Market Cap
$30.22 million
Optionable
Optionable
Beta
0.92
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:NSPR) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners